Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intranasal Injection of Platelet-rich Plasma Versus Saline for Treatment of Olfactory Dysfunction

NCT04406584 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT04406584
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04406584 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intranasal Injection of Platelet-rich Plasma Versus Saline for Treatment of Olfactory Dysfunction
Lead sponsor
Stanford University
Phase
Not applicable
Overall status
Completed
Start date
June 22, 2021
Completion date
August 11, 2022
Enrollment
30 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

covid19, olfaction disorders, olfactory disorder, olfactory nerve diseases, olfactory nerve disorder, olfactory nerve injuries, post-viral disorder